Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CONTACT: FOR ADDITIONAL INFORMATION CONTACT:                  Gemoscan Canada, Inc.         Brian Kalish         Director, President and CEO         (416) 650-1200         Email: bkalish@hemocode.com                  Company website: www.gemoscan.com

If you liked this article you might like

What's Doing Best in New Portfolio? Take a Guess

Random Action as Market Prepares for Jackson Hole

We're Seeing the First Signs of Serious Efforts on Tax Reform: Market Recon

Happy Early Returns From This Value-Oriented Dividend Portfolio